Strategies for Reaching a $300 Billion Indian Bioeconomy by 2030

Advanced Biology
Written By Shambhavi Naik

Published March 19, 2024

Executive Summary

India’s bioeconomy has been increasing its share of the national GDP. COVID-19 provided a fillip to this share. However, COVID-19 was a black swan event, and its waning influence is reflected in the reduced bioeconomy growth rate. India’s future trajectory should account for the COVID-19 aberration and provide roadmaps that recommend substitutes. This report recommends 15 steps to fulfil India’s aim of achieving a $300 billion bioeconomy by 2030.

This report is co-authored by Abhed Manocha, Roshan Valiathan & Dhritiman Borkakoti.

Author

Featured
Shambhavi Naik
Shambhavi Naik

Shambhavi Naik is the Head of Research at Takshashila and is the chairperson of the Advanced Biology programme. She has a PhD in Cancer Biology. Shambhavi’s research covers India’s policies in areas of emerging technologies, with a focus on healthcare and higher education.

Shambhavi Naik
Previous

Supply Chain and Market Scale: India as the Next China?
Next

Artificial Intelligence: Impact and Governance